VOL. XCIV, NO. 247

★ FINANCIAL TOOLS & SERVICES DIRECTORY ★

PRICE: 5 CENTS

Sunday, October 19, 2025

Head-to-head

InvestorGain vs ORTEX comparison

Compare pricing, supported platforms, categories, and standout capabilities to decide which tool fits your workflow.

Quick takeaways

InvestorGain adds IPO, Buybacks & Authorizations, Secondary Offerings, New Issues & Calendars, and Education coverage that ORTEX skips.

ORTEX includes Short Interest, Insider Data, Quant, Data Visualizations, Index Rebalancing, Money Flow, Options & Derivatives, Options, Analyst Recommendations, Analyst Price Targets, News, Data APIs, US Government Trades, and Screeners categories that InvestorGain omits.

InvestorGain highlights: Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP)., Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues., and IPO anchor investor allocation reports by year (mainboard & SME)..

ORTEX is known for: Short interest and lending analytics including utilization, cost to borrow, shares on loan, and percentage of free float on loan, with intraday and real-time estimates from a large pool of lenders and brokers., Official U.S. exchange-reported short interest (bi-monthly) and European flagged shorts, alongside lending-based estimates., and Options coverage with unusual activity and flow detection; OPRA-sourced data gated by user agreement to OPRA terms..

InvestorGain logo

InvestorGain

investorgain.com

India‑focused IPO & primary‑markets portal with live IPO subscription tracking, Grey Market Premium (GMP) dashboards, anchor investor allocations, and new‑issue calendars (NCDs, SGBs, rights). Provides broker reviews/comparisons and free brokerage calculators. GMP is expressly noted as based on market perception/public sources; the site states it does not work with GMP operators and content is for education/news. The business is ad/affiliate‑supported.

Platforms

Web
Mobile

Pricing

Free

Quick highlights

  • Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP).
  • Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues.
  • IPO anchor investor allocation reports by year (mainboard & SME).
  • IPO performance history and GMP‑vs‑actual listing performance trackers.
  • Rights issues dashboard (record date, entitlement, pricing, timelines).

Community votes (overall)

0% upvotes 0% downvotes
You haven't voted yet
ORTEX logo

ORTEX

public.ortex.com

Hands-on review

Analytics platform focused on short interest and securities lending, with additional coverage of options flow, insider trades, analyst views, and index rebalances. Offers a free tier with limited features, plus paid plans (Basic $39/mo, Advanced $129/mo). Options data is sourced from OPRA and requires agreeing to OPRA terms. API access is available with key-based authentication, and an Excel Add-in (beta) supports short interest data.

Platforms

Web
Mobile
API

Pricing

Free
Subscription

Quick highlights

  • Short interest and lending analytics including utilization, cost to borrow, shares on loan, and percentage of free float on loan, with intraday and real-time estimates from a large pool of lenders and brokers.
  • Official U.S. exchange-reported short interest (bi-monthly) and European flagged shorts, alongside lending-based estimates.
  • Options coverage with unusual activity and flow detection; OPRA-sourced data gated by user agreement to OPRA terms.
  • Alpha trading signals across themes like Short Squeeze, EPS, RSI, MACD, and Company Events, each with back-tested stats and intraday updates.
  • Configurable stock screener including short-interest columns; results can be exported.

Community votes (overall)

0% upvotes 0% downvotes
You haven't voted yet
Overlap

Shared focus areas

2 overlaps

Mutual strengths include Calendar, and Blogs.

Where they differ

InvestorGain

Distinct strengths include:

  • Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP).
  • Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues.
  • IPO anchor investor allocation reports by year (mainboard & SME).
  • IPO performance history and GMP‑vs‑actual listing performance trackers.

ORTEX

Distinct strengths include:

  • Short interest and lending analytics including utilization, cost to borrow, shares on loan, and percentage of free float on loan, with intraday and real-time estimates from a large pool of lenders and brokers.
  • Official U.S. exchange-reported short interest (bi-monthly) and European flagged shorts, alongside lending-based estimates.
  • Options coverage with unusual activity and flow detection; OPRA-sourced data gated by user agreement to OPRA terms.
  • Alpha trading signals across themes like Short Squeeze, EPS, RSI, MACD, and Company Events, each with back-tested stats and intraday updates.

Feature-by-feature breakdown

AttributeInvestorGainORTEX
Categories

Which research workflows each platform targets

Shared: Calendar, Blogs

Unique: IPO, Buybacks & Authorizations, Secondary Offerings, New Issues & Calendars, Education

Shared: Calendar, Blogs

Unique: Short Interest, Insider Data, Quant, Data Visualizations, Index Rebalancing, Money Flow, Options & Derivatives, Options, Analyst Recommendations, Analyst Price Targets, News, Data APIs, US Government Trades, Screeners

Asset types

Supported asset classes and universes

Stocks, Bonds

Stocks, ETFs, Options

Experience levels

Who each product is built for

Beginner, Intermediate, Advanced

Beginner, Intermediate, Advanced

Platforms

Where you can access the product

Web, Mobile

Web, Mobile, API

Pricing

High-level pricing models

Free

Free, Subscription

Key features

Core capabilities called out by each vendor

Unique

  • Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP).
  • Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues.
  • IPO anchor investor allocation reports by year (mainboard & SME).
  • IPO performance history and GMP‑vs‑actual listing performance trackers.
  • Rights issues dashboard (record date, entitlement, pricing, timelines).
  • NCD (Non‑Convertible Debenture) issues tracker (coupon, rating, tenor, series).

Unique

  • Short interest and lending analytics including utilization, cost to borrow, shares on loan, and percentage of free float on loan, with intraday and real-time estimates from a large pool of lenders and brokers.
  • Official U.S. exchange-reported short interest (bi-monthly) and European flagged shorts, alongside lending-based estimates.
  • Options coverage with unusual activity and flow detection; OPRA-sourced data gated by user agreement to OPRA terms.
  • Alpha trading signals across themes like Short Squeeze, EPS, RSI, MACD, and Company Events, each with back-tested stats and intraday updates.
  • Configurable stock screener including short-interest columns; results can be exported.
  • Live intraday charts with last price and bid/ask displayed.
Tested

Verified by hands-on testing inside Find My Moat

Not yet

Yes

Editor pick

Featured inside curated shortlists

Standard listing

Standard listing

Frequently Asked Questions

Which workflows do InvestorGain and ORTEX both support?

Both platforms cover Calendar, and Blogs workflows, so you can research those use cases in either tool before digging into the feature differences below.

Do InvestorGain and ORTEX require subscriptions?

Both InvestorGain and ORTEX keep freemium access with optional paid upgrades, so you can trial each platform before committing.

How can you access InvestorGain and ORTEX?

Both InvestorGain and ORTEX support web and mobile access, making it easy to keep tabs on research away from the desk.

What unique strengths set the two platforms apart?

InvestorGain differentiates itself with Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP)., Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues., and IPO anchor investor allocation reports by year (mainboard & SME)., whereas ORTEX stands out for Short interest and lending analytics including utilization, cost to borrow, shares on loan, and percentage of free float on loan, with intraday and real-time estimates from a large pool of lenders and brokers., Official U.S. exchange-reported short interest (bi-monthly) and European flagged shorts, alongside lending-based estimates., and Options coverage with unusual activity and flow detection; OPRA-sourced data gated by user agreement to OPRA terms..

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.